NRC hits Philadelphia VA with $227,500 fine

Mar 16, 2010

The U.S. Nuclear Regulatory Commission (NRC) has proposed a $227,500 fine against the U.S. Department of Veterans Affairs (VA) for violations of NRC regulations associated with errors in the prostate brachytherapy program at the VA hospital in Philadelphia.

Click here to read the rest of the article.

Latest in Radiation Oncology/Therapy
Radiation Therapy Suite
Alliance for Clinical Trials in Oncology launches prostate cancer trial
January 5, 2026
Prostate Imaging
What are Pluvicto discontinuation rates in a real-world setting?
January 5, 2026
Astro 2019
ASTRO introduces new research foundation approach
January 2, 2026
Proton Therapy
Proton therapy effective for patients with oropharyngeal cancer
December 15, 2025
Related Stories
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Medical groups tell Congress more radiation rules are needed
2009 11 12 17 39 08 655 2009 03 02 Radioactive Symbol
Nuclear Medicine
FDA launches initiative to rein in medical radiation
2009 03 25 14 14 33 939 Capitol Hill 70
Digital X-Ray
Congress sets hearing to review medical radiation
2009 01 15 16 03 49 510 Med Phys Web Logo 100
Radiation Oncology/Therapy
Radiation therapy markers may have role in drug delivery
More in Radiation Oncology/Therapy
Alliance for Clinical Trials in Oncology launches prostate cancer trial
By AuntMinnie.com staff writers
The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.
January 5, 2026
Radiation Therapy Suite
What are Pluvicto discontinuation rates in a real-world setting?
By Will Morton
There is a critical need to predict nonresponders and potential discontinuers prior to treatment.
January 5, 2026
Prostate Imaging
ASTRO introduces new research foundation approach
By AuntMinnie.com staff writers
ASTRO is renaming its research foundation and highlighting new aims for the institute to go along with the update.
January 2, 2026
Astro 2019
Proton therapy effective for patients with oropharyngeal cancer
By Will Morton
The treatment targets tumors with charged particles rather than the high-energy x-rays of photon therapy.
December 15, 2025
Proton Therapy
Lunit, Daiichi Sankyo to partner on AI biomarker, oncology research
By AuntMinnie.com staff writers
Under the collaboration, Daiichi Sankyo will make use of Lunit's SCOPE uIHC and SCOPE IO.
December 15, 2025
Lunit
Telix and Varian enter research collaboration
By AuntMinnie.com staff writers
The two firms will identify opportunities to use Telix’s prostate cancer PET imaging agents in selecting patients for radiation therapy.
December 10, 2025
Acquisitions
GE HealthCare inks RT, AI partnerships
By AuntMinnie.com staff writers
GE HealthCare announced two key collaborations for its existing and new imaging technology at RSNA 2025.
December 5, 2025
Ge Hc Logo 400
ASTRO issues guidance on radiation therapy for stomach cancer
By AuntMinnie.com staff writers
The recommendations are based on a systematic review of research published from 2001 through mid-2025.
November 19, 2025
Astro
Partial breast irradiation effective in women with HR+ cancers
By Amerigo Allegretto
Stereotactic partial breast irradiation can lead to higher rates of pathological complete response in women with HR+ cancers.
November 14, 2025
Radiation Therapy Planning 400 (1)
GT Medical releases interim data for GammaTile trial
By AuntMinnie.com staff writers
The interim findings showed superior efficacy for GammaTile with a safety profile comparable to the standard of care.
October 21, 2025
Brain Abstract 400
Pluvicto reduces progression of advanced prostate cancer
By AuntMinnie.com staff writers
New study findings were presented October 19 at the European Society for Medical Oncology 2025 annual meeting in Berlin.
October 20, 2025
Prostate Imaging
Accuray taps new CEO
By AuntMinnie.com staff writers
Steve La Neve brings more than 40 years of international medical technology experience to his new position.
October 20, 2025
Accuray Astro 2019
Page 1 of 468
Next Page